Amandeep Salhotra, M.D.

(877) 460-4673
Amandeep Salhotra, M.D.
Hematologist-Oncologist
Clinical Expertise
  • Leukemia
  • Hematology & Hematopoietic Cell Transplantation
  • Hematology-Oncology
Research Area
  • Graft Manipulation Strategies
  • Chronic Graft Vs Host Disease
  • Acute Leukemias - General
Academic Appointments
  • Associate Professor, Division of Leukemia, Department of Hematology & Hematopoietic Cell Transplantation
Clinical Teams
Hematology & Hematopoietic Cell Transplantation
Leukemia
Amandeep Salhotra, M.D.,has joined City of Hope's Department of Hematology and Hematopoietic Cell Transplantation as an Associate Professor following completion of his Bone Marrow Transplant fellowship at City of Hope. Dr. Salhotra received his Bachelor of Medicine and Bachelor of Surgery degree (MBBS), as well as his MD in Pediatrics from the Maulana Azad Medical College at the University of Delhi in India. He went on to serve as Senior Resident in pediatrics at the All India Institute of Medical Sciences in New Delhi, followed by a research fellowship in Neuro-Oncology at Johns Hopkins Hospital in Baltimore, MD. He then pursued a residency in Internal Medicine, and a Hematology-Oncology fellowship at St. Elizabeth's Medical Center in Boston, MA. This was followed by an additional Hematology-Oncology fellowship at University of Virginia Medical Center in Charlottesville, VA, before coming to City of Hope in 2012. Dr. Salhotra received the Arnold P. Gold award for Humanism and Excellence in Teaching during his residency in Internal Medicine (2009), and the Farrow Fellowship award for translational cancer research in 2011, during his Hematology-Oncology fellowship. He has published 40 articles in the peer-reviewed literature and 12 abstracts. He has published 40 research papers and has been invited to speak at many national and international meetings. His clinical interests include management of patients with Acute Leukemia, Hematopoietic Cell Transplant and HCT related complications including acute and chronic Graft Versus Host Disease.

Location

Education & Experience

Degrees

  • 1992 - 2004, Doctor of Medicine degree, Maulana Azad Medical College, University of Delhi, India

Fellowship

  • 2012 - 2013, Fellow, Hematopoietic Cell Transplantation, City of Hope, Duarte, CA

  • 2010 - 2012, Fellow. Hematology-Oncology, University of Virginia Medical Center, Charlottesville, VA

  • 2009 - 2010, Fellow, Hematology-Oncology, St. Elizabeth's Medical Center, Boston, MA

  • 2004 - 2006, Post Doctoral Fellow, Neuro-Oncology, Johns Hopkins University, Baltimore, MD

Residency

  • 2006 - 2009, Resident Physician, Internal Medicine, St. Elizabeth's Medical Center, Boston, MA

  • 2002 - 2004, Senior Resident, Pediatrics, All India Institute of Medical Sciences, New Delhi, India

Professional Experience
  • 2023-present, Associate Professor, Division of Leukemia, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA

Awards & Memberships

Memberships

  • American College of Physicians

  • American Society of Hematology

  • American Society of Clinical Oncology

  • American Society of Blood and Marrow Transplantation

Publications

View all publications

  • Trial of Enasidenib Maintenance Post-Allogeneic Hematopoietic Cell Transplantation in Patients with IDH2-Mutated Acute Myeloid Leukemia. Amandeep Salhotra, Nelli Bejanyan, Dongyun Yang, Sally Mokhtari, Diana Knobler, Gabriel Park, Monzr M Al Malki, Karamjeet S Sandhu, Rawan Faramand, Ibrahim Aldoss, Andrew S Artz, Ahmed Aribi, Hany Elmariah, Firoozeh Sahebi, Joshua Mansour, Brian J Ball, Vaibhav Agrawal, Ling Li, Vinod A Pullarkat, Stephen J Forman, Guido Marcucc, Anthony S Stein, Ryotaro Nakamura. Transplant Cell Ther. 026 Jan;32(1):76.e1-76.e12. doi: 10.1016/j.jtct.2025.09.013. Epub 2025 Sep 19.
  • Long-term survival outcomes of allo-HCT in AML with fludarabine/melphalan conditioning and tacrolimus/sirolimus GVHD prophylaxis. Amandeep Salhotra, Dongyun Yang, Monzr M Al Malki, Sally Mokhtari, Diana Knobler, Vaibhav Agarwal, Karamjeet Sandhu, Gabriel Park, Ahmed Aribi, Haris Ali, Ibrahim Aldoss, Salman Otoukesh, Shukaib Arslan, Brian Ball, Paul Koller, Idoroenyi Amanam, Hoda Pourhassan, Amanda Blackmon, Pamela Becker, Vinod Pullarkat, Andrew S Artz, Eileen Smith, Guido Marcucci, Stephen Forman, Anthony Stein, Ryotaro Nakamura. Bone Marrow Transplant, 2026 Jan;61(1):82-91. doi: 10.1038/s41409-025-02738-4. Epub 2025 Nov 18.
  • Orca-T versus allogeneic hematopoietic stem cell transplantation (PRECISION-T): a multicenter, randomized phase 3 trial. Everett Meyer, Amandeep Salhotra, Arpita Gandhi, Jeremy Pantin, Sagar S Patel, Rasmus T Hoeg, Alexandra Gomez-Arteaga, Rawan G Faramand, Roni Tamari, Edmund K Waller, Satyajit Kosuri, Antonio M Jimenez Jimenez, Jennifer Holter-Chakrabarty, Bhagirathbhai Dholaria, Yi-Bin Chen, Betty K Hamilton, John M Magenau, Alireza Eghtedar, Joshua M Murray, Anna Pavlova, Nathaniel B Fernhoff, James Scott McClellan, Scott Killian, Ai Li, Robert S Negrin, Caspian Oliai. Blood. 2025 Dec 12:blood.2025031313. doi:10.1182/blood.2025031313. Online ahead of print.
  • Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease. Daniel Wolff, Corey Cutler, Stephanie J Lee, Iskra Pusic, Henrique Bittencourt, Jennifer White, Mehdi Hamadani, Sally Arai, Amandeep Salhotra, Jose A Perez-Simon, Amin Alousi, Hannah Choe, Mi Kwon, Arancha Bermúdez, Inho Kim, Gerard Socié, Saurabh Chhabra, Vedran Radojcic, Timothy O'Toole, Chuan Tian, Peter Ordentlich, Zachariah DeFilipp, Carrie L Kitko; AGAVE-201 Investigators.
    N Engl J Med. 2024 Sep 19;391(11):1002-1014. doi: 10.1056/NEJMoa2401537.
  • ROCK2 Inhibition With Belumosudil (KD025) for the Treatment of Chronic Graft-Versus-Host Disease. Madan Jagasia, Aleksandr Lazaryan, Carlos R Bachier, Amandeep Salhotra, Daniel J Weisdorf, Behyar Zoghi, James Essell, Laurie Green, Olivier Schueller, Jeegar Patel, Alexandra Zanin-Zhorov, Jonathan M Weiss, Zhongming Yang, David Eiznhamer, Sanjay K Aggarwal, Bruce R Blazar, Stephanie J Lee. J Clin Oncol. 2021 Jun 10;39(17):1888-1898. doi: 10.1200/JCO.20.02754. Epub 2021 Apr 20.
  • Targeting PRMT9-mediated arginine methylation suppresses cancer stem cell maintenance and elicits cGAS-mediated anticancer immunity. Haojie Dong, Xin He, Lei Zhang , Wei Chen, Yi-Chun Lin, Song-Bai Liu, Huafeng Wang, Le Xuan Truong Nguyen, Min Li, Yinghui Zhu, Dandan Zhao, Lucy Ghoda, Jonathan Serody, Benjamin Vincent, Leo Luznik, Ivana Gojo, Joshua Zeidner, Rui Su, Jianjun Chen, Ritin Sharma, Patrick Pirrotte, Xiwei Wu, Weidong Hu, Weidong Han, Binghui Shen, Ya-Huei Kuo, Jie Jin, Amandeep Salhotra, Jeffrey Wang, Guido Marcucci, Yun Lyna Luo, Ling Li. Nat Cancer. 2024 Apr;5(4):601-624. doi: 10.1038/s43018-024-00736-x. Epub 2024 Feb 27.

Ratings & Reviews

Ratings and reviews below are gathered from the Press Ganey Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CG CAHPS) survey. CG CAHPS is a standardized survey that is used to measure a patient's experience in the physician office setting. Ratings are an average of all responses to questions about a provider's care, with five stars being the highest.
4.9
Recommend this provider office
4.9
Provider explain in way you understand
4.9
Provider listen carefully to you
4.9
Know important info medical history
4.9
Show respect for what you say
4.9
Rate provider 0-10
4.8
Spend enough time with you
03/19/26
Very attentive and genuinely caring and has a good cheerful personality - Verified patient
02/26/26
Very good service - Verified patient
02/18/26
Dr. Sal is a special person. He really cares about what he is doing and makes you very comfortable with the process.,excellent doctor.!!! - Verified patient
11/23/25
Yes on recommendation for others. - Verified patient
11/23/25
The provider listened intensely and made adjustments as needed. - Verified patient